XIPERE

Drug Bausch & Lomb Americas Inc.
Total Payments
$1.1M
Transactions
4,431
Doctors
1,574
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $175,710 1,083 573
2023 $227,362 1,369 747
2022 $559,433 1,827 872
2021 $78,460 122 73
2020 $37,217 30 16

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $624,256 298 57.9%
Compensation for serving as faculty or as a speaker for a medical education program $224,086 237 20.8%
Food and Beverage $134,424 3,751 12.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $63,518 15 5.9%
Travel and Lodging $28,105 106 2.6%
Space rental or facility fees (teaching hospital only) $3,500 1 0.3%
Education $291.87 23 0.0%

Top Doctors Receiving Payments for XIPERE — Page 5

Doctor Specialty Location Total Records
, MD Retina Specialist Hagerstown, MD $360.04 8
, M.D Internal Medicine Philadelphia, PA $352.97 3
, MD Ophthalmology Palm Beach Gardens, FL $350.36 4
, M.D Retina Specialist Atlanta, GA $349.45 5
, MD Ophthalmology Chicago, IL $348.70 5
, M.D Retina Specialist Simpsonville, SC $347.28 18
, M.D Ophthalmology San Francisco, CA $346.36 4
, M.D Retina Specialist Phoenix, AZ $345.39 12
, M.D Ophthalmology Atlanta, GA $338.25 3
, MD Ophthalmology Sacramento, CA $333.47 4
, M.D Internal Medicine Blue Ash, OH $330.28 4
, MD Ophthalmology Chicago, IL $329.42 4
, MD Ophthalmology Newport Beach, CA $313.44 2
, M.D Ophthalmology Atlanta, GA $312.48 3
, M.D Surgery Urham, NC $310.16 4
, M.D Ophthalmology Atlanta, GA $309.39 3
, M.D Ophthalmology Atlanta, GA $308.67 3
, MD Retina Specialist Phoenix, AZ $308.34 15
, M.D Ophthalmology Los Angeles, CA $306.64 6
, MD Ophthalmology Irvine, CA $305.14 4
Avnish Deobhakta Retina Specialist Boston, MA $303.31 10
, M.D Ophthalmology Bethesda, MD $292.37 4
, M.D Ophthalmology Atlanta, GA $287.80 2
, MD Specialist Marietta, GA $287.80 2
, MD Ophthalmology Pennington, NJ $287.20 2

About XIPERE

XIPERE is a drug associated with $1.1M in payments to 1,574 healthcare providers, recorded across 4,431 transactions in the CMS Open Payments database. The primary manufacturer is Bausch & Lomb Americas Inc..

Payment data is available from 2020 to 2024. In 2024, $175,710 was paid across 1,083 transactions to 573 doctors.

The most common payment nature for XIPERE is "Consulting Fee" ($624,256, 57.9% of total).